ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002
Trading in Thrombogenics (ISIN code BE0003846632) on Euronext Brussels is on the request of company suspended from 05:46 p.m. on March, 28 2012 until the publication of a press release.